Vivo Bio Tech Limited (BOM:511509)
India · Delayed Price · Currency is INR 19.31
-0.02 (-0.10%)
At close: Aug 21, 2026
Vivo Bio Tech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 429 | 467 | 583 | 639 | 288 | 566 | |
Market Cap Growth | -51.22% | -19.89% | -8.74% | 122.12% | -49.14% | -11.02% |
Enterprise Value | 1,088 | 1,019 | 1,148 | 1,225 | 915 | 844 |
Last Close Price | 19.31 | 21.05 | 33.97 | 42.87 | 19.30 | 39.65 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 8.01 | 25.29 | 10.86 | 25.69 |
PS Ratio | 0.78 | 0.88 | 1.25 | 1.41 | 0.55 | 1.10 |
PB Ratio | 0.46 | 0.50 | 0.75 | 1.17 | 0.56 | 1.20 |
P/TBV Ratio | 1.02 | 1.11 | 1.08 | 1.38 | 0.70 | 1.69 |
P/FCF Ratio | - | - | - | 8.44 | 2.65 | - |
P/OCF Ratio | 1.23 | 1.34 | 4.93 | 4.12 | 1.94 | 3.40 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.97 | 1.91 | 2.46 | 2.70 | 1.75 | 1.64 |
EV/EBITDA Ratio | 5.17 | 4.75 | 6.23 | 6.45 | 4.72 | 5.90 |
EV/EBIT Ratio | 11.45 | 9.42 | 9.99 | 10.38 | 7.48 | 10.08 |
EV/FCF Ratio | - | - | - | 16.18 | 8.44 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.72 | 0.72 | 0.69 | 1.34 | 1.20 | 1.43 |
Debt / EBITDA Ratio | 3.20 | 3.14 | 2.93 | 3.85 | 3.22 | 4.72 |
Debt / FCF Ratio | - | - | - | 9.65 | 5.76 | - |
Net Debt / Equity Ratio | 0.71 | 0.71 | 0.68 | 1.32 | 1.18 | 1.40 |
Net Debt / EBITDA Ratio | 3.13 | 3.08 | 2.86 | 3.77 | 3.15 | 4.60 |
Net Debt / FCF Ratio | - | -26.31 | -5.05 | 9.47 | 5.63 | -1.91 |
Asset Turnover | - | 0.33 | 0.33 | 0.35 | 0.43 | 0.51 |
Inventory Turnover | - | 1.02 | 0.74 | 0.50 | 0.80 | 1.01 |
Quick Ratio | - | 0.47 | 0.48 | 0.38 | 0.68 | 0.63 |
Current Ratio | - | 0.94 | 1.51 | 1.25 | 1.27 | 1.12 |
Return on Equity (ROE) | - | -2.00% | 11.01% | 4.75% | 5.35% | 4.91% |
Return on Assets (ROA) | - | 4.21% | 5.12% | 5.67% | 6.23% | 5.18% |
Return on Invested Capital (ROIC) | -4.65% | -2.65% | 7.41% | 6.14% | 6.21% | 4.45% |
Return on Capital Employed (ROCE) | - | 7.30% | 10.00% | 11.90% | 12.50% | 8.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -6.67% | -3.66% | 12.49% | 3.95% | 9.21% | 3.89% |
FCF Yield | -5.85% | -5.37% | -17.91% | 11.85% | 37.67% | -60.95% |
Buyback Yield / Dilution | -38.35% | -36.27% | 8.33% | -12.53% | -4.66% | -4.44% |